Skip to content

Baldwin Insurance Group

US · BWIN #2474 by market cap Listed 1970
31.81 -0.02 -0.06%
Live - 5344 symbols - heartbeat 238s ago · 2026-10-07 20:02
After-hours 31.81 0.00%
Market cap
3.08B
P/B
3.48
EPS
-0.50
Reader sentiment Are you bullish or bearish on BWIN?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 3.49 In line with history 66th percentile
5-year average 3.31 · #11 of 22 in Insurance Brokers
P/E ratio -30.61 Expensive vs history 75th percentile
5-year average -54.69 · forward -96.22
P/S ratio 1.77 In line with history 49th percentile
5-year average 1.97 · forward 1.47 · #12 of 25 in Insurance Brokers

Vs. peers Insurance Brokers

Company Market cap P/E (TTM) P/B Div yield
Baldwin Insurance Group (BWIN) 3.08B -30.59 3.48 0.00%
Marsh (MRSH) 82.87B 21.20 5.46 2.07%
Arthur J. Gallagher (AJG) 58.21B 37.66 2.45 1.19%
Aon PLC (AON) 57.37B 14.91 5.98 1.13%
Willis Towers Watson (WTW) 27.00B 18.00 3.51 1.29%
Brown & Brown (BRO) 20.65B 19.72 1.64 1.05%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value39.73 Economic moatNone UncertaintyHigh

Trading 24.9% below Morningstar's fair value estimate.

Fair value

The Baldwin Insurance Group Inc earns a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 20% discount to our quantitative fair value estimate of $39.73 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's balance sheet strengthens our fair value estimate. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. For example, the firm's EBITDA/interest coverage ratio of 0.4 sits in the bottom 20% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be undervalued.

Conversely, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 20.0%, a core component of valuation, ranks in the bottom 20% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.

Economic moat

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-07 20:02:26 · For reference only, not investment advice and not tailored to your situation.